Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer

Cancer Chemotherapy and Pharmacology

Volumn 46, Issue 5, 2000, Pages 382-386

  Esteva, Francisco J ^a   Soh, Lay Tin ^a   Holmes, Frankie Ann ^a   Plunkett, William ^a   Meyers, Christina A ^a   Forman, Arthur D ^a   Hortobagyi, Gabriel N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast neoplasms; Cytosine arabinoside; Meningeal neoplasms; Treatment

Indexed keywords

CYTARABINE;

ADULT; AGED; ALOPECIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; FEMALE; HUMAN; IMPLANTABLE PORT SYSTEM; MENINGISM; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

EID: 0033747021     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000173     Document Type: Article

References (25)

1. Comprehensive criteria for assessing therapy-induced toxicity
2. High-dose 1-beta-D-arabinofuranosylcytosine in advanced breast cancer
3. Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors
4. The effect of beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells
5. Gemcitabine in leukemia: A phase I clinical, plasma, and cellular pharmacology study
6. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast
7. Extended CSF cytarabine exposure following intrathecal administration of DTC 101
8. Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoam
9. Chemotherapy of leukemia L1210 in mice with 1-beta-D-arabinofuranosylcytosine hydrochloride. II. Effectiveness against intracerebrally and subcutaneously inoculated leukemic cells
10. Long term survivors with leptomeningeal tumor involvement
11. Metastases of neoplasms to central nervous system and meninges
12. Meningeal carcinomatosis. Clinical manifestations
13. Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study
14. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy
15. Necrotizing encephalopathy following intraventricular instillation of methotrexate
16. Brain damage after intrathecal methotrexate
17. Carcinomatous meningitis associated with infiltrating lobular carcinoma of the breast
18. Meningeal carcinomatosis in patients with primary breast or lung cancer
19. Treatment of neoplastic meningitis with intraventricular thiotepa and methotrexate
20. Central nervous system metastases from breast carcinoma. Autopsy study
21. Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients
22. Treatment for meningeal carcinomatosis in breast cancer
23. Meningeal carcinomatosis in breast cancer
24. Cytosine arabinoside cerebrospinal fluid kinetics
25. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide